Renal ischemia-reperfusion injury: Renal dendritic cells loudly sound the alarm

Kidney International

Volumn 71, Issue 7, 2007, Pages 604-605

  Nelson, P J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; LIPOSOME; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; CYTOKINE RELEASE; DENDRITIC CELL; HELPER CELL; IMMUNOCOMPETENT CELL; KIDNEY ALLOGRAFT; KIDNEY EPITHELIUM; KIDNEY ISCHEMIA; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 33947659034     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002121     Document Type: Note

References (10)

1. Dong X, Swaminathan S, Bachman LA et al. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 2007; 71: 619-628.
2. Soos TJ, Sims TN, Barisoni L et al. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 2006; 70: 591-596.
3. Aggarwal BB. Signaling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-756.
4. Fiorina P, Ansari MJ, Jurewicz M et al. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J Am Soc Nephrol 2006; 17: 716-723.
5. Avihingsanon Y, Ma N, Pavlakis M et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2006; 16: 1542-1548.
6. El-Achkar TM, Dagher PC. Renal Toll-like receptors: recent advances and implications for disease. Nat Clin Pract Nephrol 2006; 2: 568-581.
7. Cunningham PN, Dyanov HM, Park P et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168: 5817-5823.
8. Cunningham PN, Wang Y, Guo R et al. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 2004; 172: 2629-2635.
9. Martin M, Rehani K, Jope RS et al. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 2005; 6: 777-784.
10. Soos TJ, Meijer L, Nelson PJ. CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseases. Drug News Perspect 2006; 19: 325-328.